Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound

摘要

A therapeutic composition containing an antimicrobial hexahydro-5-pyrimidinamine compound and an anesthetic morpholine-ether compound in a pharmaceutically acceptable carrier is disclosed. The composition may be an oral topical composition or a non-oral topical composition. The preferred hexahydro-5-pyrimidinamine composition is hexetidine. The preferred morpholine-ether composition is pramoxine(4-[3-(4-butoryphenoxy)prozsyl]morpholine).